Can the hidden dialogue between our immune system and our salt intake explain why some individuals are more susceptible to cardiovascular disease than others? This is the fundamental question driving the work of Mohammad Saleem, a research instructor in the Division of Genetic Medicine and Clinical Pharmacology at Vanderbilt Health. By focusing on the mechanics of how high dietary sodium disrupts immune regulation, his research seeks to move beyond the simple correlation between salt and high blood pressure, aiming instead to map the biological pathways that trigger disease.
Honoring a Legacy of Pharmacological Innovation
On April 25, Saleem was presented with the 2026 Shih‐Chun Wang Young Investigator Award from the American Physiological Society during the American Physiology Summit in Minneapolis. The award, which recognizes researchers who demonstrate "outstanding promise" in the physiological sciences, carries a specific historical weight. It is named for the late Shih-Chun Wang, a Columbia University pharmacologist whose pioneering work in the 20th century led to the development of drugs designed to prevent motion sickness-related vomiting. Like Wang’s foundational research, which addressed a common but poorly understood physiological reflex, Saleem’s current trajectory aims to illuminate the underlying mechanisms of salt-sensitivity of blood pressure (SSBP).
Decoding the Immune-Salt Connection
While public health discourse often simplifies the relationship between salt and hypertension, the reality is far more nuanced. Many headlines suggest that salt intake is a binary "good" or "bad" variable, but Saleem’s research treats salt as a modulator of immune function. The $10,000 grant associated with this one-year award is designated to support his ongoing investigations into immune cell-mediated SSBP, which is widely recognized in medical literature as an independent risk factor for cardiovascular disease and mortality. By bridging the gap between salt-sensitive hypertension and autoimmunity, Saleem is investigating how high sodium levels may actively alter immune responses, rather than simply exerting pressure on the vascular system through fluid retention.
The Path from Houston to Vanderbilt
Saleem’s approach is built upon a foundation of extensive academic and clinical training. After earning his PhD in Pharmacological and Pharmaceutical Sciences from the University of Houston, he refined his expertise through two postdoctoral research fellowships at Vanderbilt Health. He currently conducts his work as a member of the lab of Annet Kirabo, an associate professor of Medicine at Vanderbilt. This environment has allowed him to integrate clinical pharmacology with advanced immunological study, a multidisciplinary approach necessary for dissecting the complex interplay between diet and cellular health.
Limitations and Future Investigations
It is important to maintain a measured perspective regarding the current state of this research. While the mechanism of immune cell-mediated SSBP offers a compelling explanation for why blood pressure regulation fails in certain populations, the field is still in the process of translating these molecular findings into therapeutic interventions. Current research is largely focused on uncovering these mechanisms in controlled settings, and translating these insights into human clinical outcomes remains a significant hurdle. The next steps in this research will involve further elucidating how dietary sodium levels disrupt immune homeostasis. The ongoing analysis of these immune pathways will determine whether these biological markers can eventually be used to predict which patients are at the highest risk for salt-induced hypertension, potentially shifting the focus of cardiovascular prevention from broad dietary guidelines to personalized, immune-targeted strategies.
